 | • レポートコード：MRC2-11QY01927 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、118ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：化学・材料 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は1,4,7,10-テトラアザシクロドデカンのグローバル市場について調査・分析したレポートです。種類別（化学用、医薬用）市場規模、用途別（プロハンス、ガダビスト、ドタレム）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別1,4,7,10-テトラアザシクロドデカンの競争状況、市場シェア ・世界の1,4,7,10-テトラアザシクロドデカン市場：種類別市場規模 2015年-2020年（化学用、医薬用） ・世界の1,4,7,10-テトラアザシクロドデカン市場：種類別市場規模予測 2021年-2026年（化学用、医薬用） ・世界の1,4,7,10-テトラアザシクロドデカン市場：用途別市場規模 2015年-2020年（プロハンス、ガダビスト、ドタレム） ・世界の1,4,7,10-テトラアザシクロドデカン市場：用途別市場規模予測 2021年-2026年（プロハンス、ガダビスト、ドタレム） ・北米の1,4,7,10-テトラアザシクロドデカン市場分析：米国、カナダ ・ヨーロッパの1,4,7,10-テトラアザシクロドデカン市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの1,4,7,10-テトラアザシクロドデカン市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の1,4,7,10-テトラアザシクロドデカン市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの1,4,7,10-テトラアザシクロドデカン市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Guerbet、Bayer Vital、Bracco、Bolon、Hubei Tianshu、Heryi Pharma、Taicang Qianjing、Chem Stone、Nanhua、Xiamen Huasing ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Market Analysis and Insights: Global 1,4,7,10-Tetraazacyclododecane Market
The global 1,4,7,10-Tetraazacyclododecane market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global 1,4,7,10-Tetraazacyclododecane Scope and Market Size
1,4,7,10-Tetraazacyclododecane market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global 1,4,7,10-Tetraazacyclododecane market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the 1,4,7,10-Tetraazacyclododecane market is segmented into
Chemical Grade
Pharmaceutical Grade
Segment by Application, the 1,4,7,10-Tetraazacyclododecane market is segmented into
ProHance
Gadavist
Dotarem
Regional and Country-level Analysis
The 1,4,7,10-Tetraazacyclododecane market is analysed and market size information is provided by regions (countries).
The key regions covered in the 1,4,7,10-Tetraazacyclododecane market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and 1,4,7,10-Tetraazacyclododecane Market Share Analysis
1,4,7,10-Tetraazacyclododecane market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in 1,4,7,10-Tetraazacyclododecane business, the date to enter into the 1,4,7,10-Tetraazacyclododecane market, 1,4,7,10-Tetraazacyclododecane product introduction, recent developments, etc.
The major vendors covered:
Guerbet
Bayer Vital
Bracco
Bolon
Hubei Tianshu
Heryi Pharma
Taicang Qianjing
Chem Stone
Nanhua
Xiamen Huasing
1 Study Coverage
1.1 1,4,7,10-Tetraazacyclododecane Product Introduction
1.2 Market Segments
1.3 Key 1,4,7,10-Tetraazacyclododecane Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global 1,4,7,10-Tetraazacyclododecane Market Size Growth Rate by Type
1.4.2 Chemical Grade
1.4.3 Pharmaceutical Grade
1.5 Market by Application
1.5.1 Global 1,4,7,10-Tetraazacyclododecane Market Size Growth Rate by Application
1.5.2 ProHance
1.5.3 Gadavist
1.5.4 Dotarem
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global 1,4,7,10-Tetraazacyclododecane Market Size, Estimates and Forecasts
2.1.1 Global 1,4,7,10-Tetraazacyclododecane Revenue 2015-2026
2.1.2 Global 1,4,7,10-Tetraazacyclododecane Sales 2015-2026
2.2 Global 1,4,7,10-Tetraazacyclododecane, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global 1,4,7,10-Tetraazacyclododecane Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global 1,4,7,10-Tetraazacyclododecane Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global 1,4,7,10-Tetraazacyclododecane Competitor Landscape by Players
3.1 1,4,7,10-Tetraazacyclododecane Sales by Manufacturers
3.1.1 1,4,7,10-Tetraazacyclododecane Sales by Manufacturers (2015-2020)
3.1.2 1,4,7,10-Tetraazacyclododecane Sales Market Share by Manufacturers (2015-2020)
3.2 1,4,7,10-Tetraazacyclododecane Revenue by Manufacturers
3.2.1 1,4,7,10-Tetraazacyclododecane Revenue by Manufacturers (2015-2020)
3.2.2 1,4,7,10-Tetraazacyclododecane Revenue Share by Manufacturers (2015-2020)
3.2.3 Global 1,4,7,10-Tetraazacyclododecane Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by 1,4,7,10-Tetraazacyclododecane Revenue in 2019
3.2.5 Global 1,4,7,10-Tetraazacyclododecane Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 1,4,7,10-Tetraazacyclododecane Price by Manufacturers
3.4 1,4,7,10-Tetraazacyclododecane Manufacturing Base Distribution, Product Types
3.4.1 1,4,7,10-Tetraazacyclododecane Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers 1,4,7,10-Tetraazacyclododecane Product Type
3.4.3 Date of International Manufacturers Enter into 1,4,7,10-Tetraazacyclododecane Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global 1,4,7,10-Tetraazacyclododecane Market Size by Type (2015-2020)
4.1.1 Global 1,4,7,10-Tetraazacyclododecane Sales by Type (2015-2020)
4.1.2 Global 1,4,7,10-Tetraazacyclododecane Revenue by Type (2015-2020)
4.1.3 1,4,7,10-Tetraazacyclododecane Average Selling Price (ASP) by Type (2015-2026)
4.2 Global 1,4,7,10-Tetraazacyclododecane Market Size Forecast by Type (2021-2026)
4.2.1 Global 1,4,7,10-Tetraazacyclododecane Sales Forecast by Type (2021-2026)
4.2.2 Global 1,4,7,10-Tetraazacyclododecane Revenue Forecast by Type (2021-2026)
4.2.3 1,4,7,10-Tetraazacyclododecane Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global 1,4,7,10-Tetraazacyclododecane Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global 1,4,7,10-Tetraazacyclododecane Market Size by Application (2015-2020)
5.1.1 Global 1,4,7,10-Tetraazacyclododecane Sales by Application (2015-2020)
5.1.2 Global 1,4,7,10-Tetraazacyclododecane Revenue by Application (2015-2020)
5.1.3 1,4,7,10-Tetraazacyclododecane Price by Application (2015-2020)
5.2 1,4,7,10-Tetraazacyclododecane Market Size Forecast by Application (2021-2026)
5.2.1 Global 1,4,7,10-Tetraazacyclododecane Sales Forecast by Application (2021-2026)
5.2.2 Global 1,4,7,10-Tetraazacyclododecane Revenue Forecast by Application (2021-2026)
5.2.3 Global 1,4,7,10-Tetraazacyclododecane Price Forecast by Application (2021-2026)
6 North America
6.1 North America 1,4,7,10-Tetraazacyclododecane by Country
6.1.1 North America 1,4,7,10-Tetraazacyclododecane Sales by Country
6.1.2 North America 1,4,7,10-Tetraazacyclododecane Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America 1,4,7,10-Tetraazacyclododecane Market Facts & Figures by Type
6.3 North America 1,4,7,10-Tetraazacyclododecane Market Facts & Figures by Application
7 Europe
7.1 Europe 1,4,7,10-Tetraazacyclododecane by Country
7.1.1 Europe 1,4,7,10-Tetraazacyclododecane Sales by Country
7.1.2 Europe 1,4,7,10-Tetraazacyclododecane Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe 1,4,7,10-Tetraazacyclododecane Market Facts & Figures by Type
7.3 Europe 1,4,7,10-Tetraazacyclododecane Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific 1,4,7,10-Tetraazacyclododecane by Region
8.1.1 Asia Pacific 1,4,7,10-Tetraazacyclododecane Sales by Region
8.1.2 Asia Pacific 1,4,7,10-Tetraazacyclododecane Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific 1,4,7,10-Tetraazacyclododecane Market Facts & Figures by Type
8.3 Asia Pacific 1,4,7,10-Tetraazacyclododecane Market Facts & Figures by Application
9 Latin America
9.1 Latin America 1,4,7,10-Tetraazacyclododecane by Country
9.1.1 Latin America 1,4,7,10-Tetraazacyclododecane Sales by Country
9.1.2 Latin America 1,4,7,10-Tetraazacyclododecane Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America 1,4,7,10-Tetraazacyclododecane Market Facts & Figures by Type
9.3 Central & South America 1,4,7,10-Tetraazacyclododecane Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa 1,4,7,10-Tetraazacyclododecane by Country
10.1.1 Middle East and Africa 1,4,7,10-Tetraazacyclododecane Sales by Country
10.1.2 Middle East and Africa 1,4,7,10-Tetraazacyclododecane Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa 1,4,7,10-Tetraazacyclododecane Market Facts & Figures by Type
10.3 Middle East and Africa 1,4,7,10-Tetraazacyclododecane Market Facts & Figures by Application
11 Company Profiles
11.1 Guerbet
11.1.1 Guerbet Corporation Information
11.1.2 Guerbet Description and Business Overview
11.1.3 Guerbet Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Guerbet 1,4,7,10-Tetraazacyclododecane Products Offered
11.1.5 Guerbet Related Developments
11.2 Bayer Vital
11.2.1 Bayer Vital Corporation Information
11.2.2 Bayer Vital Description and Business Overview
11.2.3 Bayer Vital Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Bayer Vital 1,4,7,10-Tetraazacyclododecane Products Offered
11.2.5 Bayer Vital Related Developments
11.3 Bracco
11.3.1 Bracco Corporation Information
11.3.2 Bracco Description and Business Overview
11.3.3 Bracco Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Bracco 1,4,7,10-Tetraazacyclododecane Products Offered
11.3.5 Bracco Related Developments
11.4 Bolon
11.4.1 Bolon Corporation Information
11.4.2 Bolon Description and Business Overview
11.4.3 Bolon Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Bolon 1,4,7,10-Tetraazacyclododecane Products Offered
11.4.5 Bolon Related Developments
11.5 Hubei Tianshu
11.5.1 Hubei Tianshu Corporation Information
11.5.2 Hubei Tianshu Description and Business Overview
11.5.3 Hubei Tianshu Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Hubei Tianshu 1,4,7,10-Tetraazacyclododecane Products Offered
11.5.5 Hubei Tianshu Related Developments
11.6 Heryi Pharma
11.6.1 Heryi Pharma Corporation Information
11.6.2 Heryi Pharma Description and Business Overview
11.6.3 Heryi Pharma Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Heryi Pharma 1,4,7,10-Tetraazacyclododecane Products Offered
11.6.5 Heryi Pharma Related Developments
11.7 Taicang Qianjing
11.7.1 Taicang Qianjing Corporation Information
11.7.2 Taicang Qianjing Description and Business Overview
11.7.3 Taicang Qianjing Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Taicang Qianjing 1,4,7,10-Tetraazacyclododecane Products Offered
11.7.5 Taicang Qianjing Related Developments
11.8 Chem Stone
11.8.1 Chem Stone Corporation Information
11.8.2 Chem Stone Description and Business Overview
11.8.3 Chem Stone Sales, Revenue and Gross Margin (2015-2020)
11.8.4 Chem Stone 1,4,7,10-Tetraazacyclododecane Products Offered
11.8.5 Chem Stone Related Developments
11.9 Nanhua
11.9.1 Nanhua Corporation Information
11.9.2 Nanhua Description and Business Overview
11.9.3 Nanhua Sales, Revenue and Gross Margin (2015-2020)
11.9.4 Nanhua 1,4,7,10-Tetraazacyclododecane Products Offered
11.9.5 Nanhua Related Developments
11.10 Xiamen Huasing
11.10.1 Xiamen Huasing Corporation Information
11.10.2 Xiamen Huasing Description and Business Overview
11.10.3 Xiamen Huasing Sales, Revenue and Gross Margin (2015-2020)
11.10.4 Xiamen Huasing 1,4,7,10-Tetraazacyclododecane Products Offered
11.10.5 Xiamen Huasing Related Developments
11.1 Guerbet
11.1.1 Guerbet Corporation Information
11.1.2 Guerbet Description and Business Overview
11.1.3 Guerbet Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Guerbet 1,4,7,10-Tetraazacyclododecane Products Offered
11.1.5 Guerbet Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 1,4,7,10-Tetraazacyclododecane Market Estimates and Projections by Region
12.1.1 Global 1,4,7,10-Tetraazacyclododecane Sales Forecast by Regions 2021-2026
12.1.2 Global 1,4,7,10-Tetraazacyclododecane Revenue Forecast by Regions 2021-2026
12.2 North America 1,4,7,10-Tetraazacyclododecane Market Size Forecast (2021-2026)
12.2.1 North America: 1,4,7,10-Tetraazacyclododecane Sales Forecast (2021-2026)
12.2.2 North America: 1,4,7,10-Tetraazacyclododecane Revenue Forecast (2021-2026)
12.2.3 North America: 1,4,7,10-Tetraazacyclododecane Market Size Forecast by Country (2021-2026)
12.3 Europe 1,4,7,10-Tetraazacyclododecane Market Size Forecast (2021-2026)
12.3.1 Europe: 1,4,7,10-Tetraazacyclododecane Sales Forecast (2021-2026)
12.3.2 Europe: 1,4,7,10-Tetraazacyclododecane Revenue Forecast (2021-2026)
12.3.3 Europe: 1,4,7,10-Tetraazacyclododecane Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific 1,4,7,10-Tetraazacyclododecane Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: 1,4,7,10-Tetraazacyclododecane Sales Forecast (2021-2026)
12.4.2 Asia Pacific: 1,4,7,10-Tetraazacyclododecane Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: 1,4,7,10-Tetraazacyclododecane Market Size Forecast by Region (2021-2026)
12.5 Latin America 1,4,7,10-Tetraazacyclododecane Market Size Forecast (2021-2026)
12.5.1 Latin America: 1,4,7,10-Tetraazacyclododecane Sales Forecast (2021-2026)
12.5.2 Latin America: 1,4,7,10-Tetraazacyclododecane Revenue Forecast (2021-2026)
12.5.3 Latin America: 1,4,7,10-Tetraazacyclododecane Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa 1,4,7,10-Tetraazacyclododecane Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: 1,4,7,10-Tetraazacyclododecane Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: 1,4,7,10-Tetraazacyclododecane Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: 1,4,7,10-Tetraazacyclododecane Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key 1,4,7,10-Tetraazacyclododecane Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 1,4,7,10-Tetraazacyclododecane Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Table 1. 1,4,7,10-Tetraazacyclododecane Market Segments
Table 2. Ranking of Global Top 1,4,7,10-Tetraazacyclododecane Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global 1,4,7,10-Tetraazacyclododecane Market Size Growth Rate by Type 2020-2026 (K MT) & (US$ Million)
Table 4. Major Manufacturers of Chemical Grade
Table 5. Major Manufacturers of Pharmaceutical Grade
Table 6. Global 1,4,7,10-Tetraazacyclododecane Market Size Growth Rate by Application 2020-2026 (K MT)
Table 7. Global 1,4,7,10-Tetraazacyclododecane Market Size by Region (K MT) & (US$ Million): 2020 VS 2026
Table 8. Global 1,4,7,10-Tetraazacyclododecane Sales by Regions 2015-2020 (K MT)
Table 9. Global 1,4,7,10-Tetraazacyclododecane Sales Market Share by Regions (2015-2020)
Table 10. Global 1,4,7,10-Tetraazacyclododecane Revenue by Regions 2015-2020 (US$ Million)
Table 11. Global 1,4,7,10-Tetraazacyclododecane Sales by Manufacturers (2015-2020) (K MT)
Table 12. Global 1,4,7,10-Tetraazacyclododecane Sales Share by Manufacturers (2015-2020)
Table 13. Global 1,4,7,10-Tetraazacyclododecane Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 14. Global 1,4,7,10-Tetraazacyclododecane by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in 1,4,7,10-Tetraazacyclododecane as of 2019)
Table 15. 1,4,7,10-Tetraazacyclododecane Revenue by Manufacturers (2015-2020) (US$ Million)
Table 16. 1,4,7,10-Tetraazacyclododecane Revenue Share by Manufacturers (2015-2020)
Table 17. Key Manufacturers 1,4,7,10-Tetraazacyclododecane Price (2015-2020) (USD/MT)
Table 18. 1,4,7,10-Tetraazacyclododecane Manufacturers Manufacturing Base Distribution and Headquarters
Table 19. Manufacturers 1,4,7,10-Tetraazacyclododecane Product Type
Table 20. Date of International Manufacturers Enter into 1,4,7,10-Tetraazacyclododecane Market
Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 22. Global 1,4,7,10-Tetraazacyclododecane Sales by Type (2015-2020) (K MT)
Table 23. Global 1,4,7,10-Tetraazacyclododecane Sales Share by Type (2015-2020)
Table 24. Global 1,4,7,10-Tetraazacyclododecane Revenue by Type (2015-2020) (US$ Million)
Table 25. Global 1,4,7,10-Tetraazacyclododecane Revenue Share by Type (2015-2020)
Table 26. 1,4,7,10-Tetraazacyclododecane Average Selling Price (ASP) by Type 2015-2020 (USD/MT)
Table 27. Global 1,4,7,10-Tetraazacyclododecane Sales by Application (2015-2020) (K MT)
Table 28. Global 1,4,7,10-Tetraazacyclododecane Sales Share by Application (2015-2020)
Table 29. North America 1,4,7,10-Tetraazacyclododecane Sales by Country (2015-2020) (K MT)
Table 30. North America 1,4,7,10-Tetraazacyclododecane Sales Market Share by Country (2015-2020)
Table 31. North America 1,4,7,10-Tetraazacyclododecane Revenue by Country (2015-2020) (US$ Million)
Table 32. North America 1,4,7,10-Tetraazacyclododecane Revenue Market Share by Country (2015-2020)
Table 33. North America 1,4,7,10-Tetraazacyclododecane Sales by Type (2015-2020) (K MT)
Table 34. North America 1,4,7,10-Tetraazacyclododecane Sales Market Share by Type (2015-2020)
Table 35. North America 1,4,7,10-Tetraazacyclododecane Sales by Application (2015-2020) (K MT)
Table 36. North America 1,4,7,10-Tetraazacyclododecane Sales Market Share by Application (2015-2020)
Table 37. Europe 1,4,7,10-Tetraazacyclododecane Sales by Country (2015-2020) (K MT)
Table 38. Europe 1,4,7,10-Tetraazacyclododecane Sales Market Share by Country (2015-2020)
Table 39. Europe 1,4,7,10-Tetraazacyclododecane Revenue by Country (2015-2020) (US$ Million)
Table 40. Europe 1,4,7,10-Tetraazacyclododecane Revenue Market Share by Country (2015-2020)
Table 41. Europe 1,4,7,10-Tetraazacyclododecane Sales by Type (2015-2020) (K MT)
Table 42. Europe 1,4,7,10-Tetraazacyclododecane Sales Market Share by Type (2015-2020)
Table 43. Europe 1,4,7,10-Tetraazacyclododecane Sales by Application (2015-2020) (K MT)
Table 44. Europe 1,4,7,10-Tetraazacyclododecane Sales Market Share by Application (2015-2020)
Table 45. Asia Pacific 1,4,7,10-Tetraazacyclododecane Sales by Region (2015-2020) (K MT)
Table 46. Asia Pacific 1,4,7,10-Tetraazacyclododecane Sales Market Share by Region (2015-2020)
Table 47. Asia Pacific 1,4,7,10-Tetraazacyclododecane Revenue by Region (2015-2020) (US$ Million)
Table 48. Asia Pacific 1,4,7,10-Tetraazacyclododecane Revenue Market Share by Region (2015-2020)
Table 49. Asia Pacific 1,4,7,10-Tetraazacyclododecane Sales by Type (2015-2020) (K MT)
Table 50. Asia Pacific 1,4,7,10-Tetraazacyclododecane Sales Market Share by Type (2015-2020)
Table 51. Asia Pacific 1,4,7,10-Tetraazacyclododecane Sales by Application (2015-2020) (K MT)
Table 52. Asia Pacific 1,4,7,10-Tetraazacyclododecane Sales Market Share by Application (2015-2020)
Table 53. Latin America 1,4,7,10-Tetraazacyclododecane Sales by Country (2015-2020) (K MT)
Table 54. Latin America 1,4,7,10-Tetraazacyclododecane Sales Market Share by Country (2015-2020)
Table 55. Latin Americaa 1,4,7,10-Tetraazacyclododecane Revenue by Country (2015-2020) (US$ Million)
Table 56. Latin America 1,4,7,10-Tetraazacyclododecane Revenue Market Share by Country (2015-2020)
Table 57. Latin America 1,4,7,10-Tetraazacyclododecane Sales by Type (2015-2020) (K MT)
Table 58. Latin America 1,4,7,10-Tetraazacyclododecane Sales Market Share by Type (2015-2020)
Table 59. Latin America 1,4,7,10-Tetraazacyclododecane Sales by Application (2015-2020) (K MT)
Table 60. Latin America 1,4,7,10-Tetraazacyclododecane Sales Market Share by Application (2015-2020)
Table 61. Middle East and Africa 1,4,7,10-Tetraazacyclododecane Sales by Country (2015-2020) (K MT)
Table 62. Middle East and Africa 1,4,7,10-Tetraazacyclododecane Sales Market Share by Country (2015-2020)
Table 63. Middle East and Africa 1,4,7,10-Tetraazacyclododecane Revenue by Country (2015-2020) (US$ Million)
Table 64. Middle East and Africa 1,4,7,10-Tetraazacyclododecane Revenue Market Share by Country (2015-2020)
Table 65. Middle East and Africa 1,4,7,10-Tetraazacyclododecane Sales by Type (2015-2020) (K MT)
Table 66. Middle East and Africa 1,4,7,10-Tetraazacyclododecane Sales Market Share by Type (2015-2020)
Table 67. Middle East and Africa 1,4,7,10-Tetraazacyclododecane Sales by Application (2015-2020) (K MT)
Table 68. Middle East and Africa 1,4,7,10-Tetraazacyclododecane Sales Market Share by Application (2015-2020)
Table 69. Guerbet Corporation Information
Table 70. Guerbet Description and Major Businesses
Table 71. Guerbet 1,4,7,10-Tetraazacyclododecane Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 72. Guerbet Product
Table 73. Guerbet Recent Development
Table 74. Bayer Vital Corporation Information
Table 75. Bayer Vital Description and Major Businesses
Table 76. Bayer Vital 1,4,7,10-Tetraazacyclododecane Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 77. Bayer Vital Product
Table 78. Bayer Vital Recent Development
Table 79. Bracco Corporation Information
Table 80. Bracco Description and Major Businesses
Table 81. Bracco 1,4,7,10-Tetraazacyclododecane Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 82. Bracco Product
Table 83. Bracco Recent Development
Table 84. Bolon Corporation Information
Table 85. Bolon Description and Major Businesses
Table 86. Bolon 1,4,7,10-Tetraazacyclododecane Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 87. Bolon Product
Table 88. Bolon Recent Development
Table 89. Hubei Tianshu Corporation Information
Table 90. Hubei Tianshu Description and Major Businesses
Table 91. Hubei Tianshu 1,4,7,10-Tetraazacyclododecane Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 92. Hubei Tianshu Product
Table 93. Hubei Tianshu Recent Development
Table 94. Heryi Pharma Corporation Information
Table 95. Heryi Pharma Description and Major Businesses
Table 96. Heryi Pharma 1,4,7,10-Tetraazacyclododecane Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 97. Heryi Pharma Product
Table 98. Heryi Pharma Recent Development
Table 99. Taicang Qianjing Corporation Information
Table 100. Taicang Qianjing Description and Major Businesses
Table 101. Taicang Qianjing 1,4,7,10-Tetraazacyclododecane Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 102. Taicang Qianjing Product
Table 103. Taicang Qianjing Recent Development
Table 104. Chem Stone Corporation Information
Table 105. Chem Stone Description and Major Businesses
Table 106. Chem Stone 1,4,7,10-Tetraazacyclododecane Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 107. Chem Stone Product
Table 108. Chem Stone Recent Development
Table 109. Nanhua Corporation Information
Table 110. Nanhua Description and Major Businesses
Table 111. Nanhua 1,4,7,10-Tetraazacyclododecane Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 112. Nanhua Product
Table 113. Nanhua Recent Development
Table 114. Xiamen Huasing Corporation Information
Table 115. Xiamen Huasing Description and Major Businesses
Table 116. Xiamen Huasing 1,4,7,10-Tetraazacyclododecane Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 117. Xiamen Huasing Product
Table 118. Xiamen Huasing Recent Development
Table 119. Global 1,4,7,10-Tetraazacyclododecane Sales Forecast by Regions (2021-2026) (K MT)
Table 120. Global 1,4,7,10-Tetraazacyclododecane Sales Market Share Forecast by Regions (2021-2026)
Table 121. Global 1,4,7,10-Tetraazacyclododecane Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 122. Global 1,4,7,10-Tetraazacyclododecane Revenue Market Share Forecast by Regions (2021-2026)
Table 123. North America: 1,4,7,10-Tetraazacyclododecane Sales Forecast by Country (2021-2026) (K MT)
Table 124. North America: 1,4,7,10-Tetraazacyclododecane Revenue Forecast by Country (2021-2026) (US$ Million)
Table 125. Europe: 1,4,7,10-Tetraazacyclododecane Sales Forecast by Country (2021-2026) (K MT)
Table 126. Europe: 1,4,7,10-Tetraazacyclododecane Revenue Forecast by Country (2021-2026) (US$ Million)
Table 127. Asia Pacific: 1,4,7,10-Tetraazacyclododecane Sales Forecast by Region (2021-2026) (K MT)
Table 128. Asia Pacific: 1,4,7,10-Tetraazacyclododecane Revenue Forecast by Region (2021-2026) (US$ Million)
Table 129. Latin America: 1,4,7,10-Tetraazacyclododecane Sales Forecast by Country (2021-2026) (K MT)
Table 130. Latin America: 1,4,7,10-Tetraazacyclododecane Revenue Forecast by Country (2021-2026) (US$ Million)
Table 131. Middle East and Africa: 1,4,7,10-Tetraazacyclododecane Sales Forecast by Country (2021-2026) (K MT)
Table 132. Middle East and Africa: 1,4,7,10-Tetraazacyclododecane Revenue Forecast by Country (2021-2026) (US$ Million)
Table 133. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 134. Key Challenges
Table 135. Market Risks
Table 136. Main Points Interviewed from Key 1,4,7,10-Tetraazacyclododecane Players
Table 137. 1,4,7,10-Tetraazacyclododecane Customers List
Table 138. 1,4,7,10-Tetraazacyclododecane Distributors List
Table 139. Research Programs/Design for This Report
Table 140. Key Data Information from Secondary Sources
Table 141. Key Data Information from Primary Sources
List of Figures
Figure 1. 1,4,7,10-Tetraazacyclododecane Product Picture
Figure 2. Global 1,4,7,10-Tetraazacyclododecane Sales Market Share by Type in 2020 & 2026
Figure 3. Chemical Grade Product Picture
Figure 4. Pharmaceutical Grade Product Picture
Figure 5. Global 1,4,7,10-Tetraazacyclododecane Sales Market Share by Application in 2020 & 2026
Figure 6. ProHance
Figure 7. Gadavist
Figure 8. Dotarem
Figure 9. 1,4,7,10-Tetraazacyclododecane Report Years Considered
Figure 10. Global 1,4,7,10-Tetraazacyclododecane Market Size 2015-2026 (US$ Million)
Figure 11. Global 1,4,7,10-Tetraazacyclododecane Sales 2015-2026 (K MT)
Figure 12. Global 1,4,7,10-Tetraazacyclododecane Market Size Market Share by Region: 2020 Versus 2026
Figure 13. Global 1,4,7,10-Tetraazacyclododecane Sales Market Share by Region (2015-2020)
Figure 14. Global 1,4,7,10-Tetraazacyclododecane Sales Market Share by Region in 2019
Figure 15. Global 1,4,7,10-Tetraazacyclododecane Revenue Market Share by Region (2015-2020)
Figure 16. Global 1,4,7,10-Tetraazacyclododecane Revenue Market Share by Region in 2019
Figure 17. Global 1,4,7,10-Tetraazacyclododecane Sales Share by Manufacturer in 2019
Figure 18. The Top 10 and 5 Players Market Share by 1,4,7,10-Tetraazacyclododecane Revenue in 2019
Figure 19. 1,4,7,10-Tetraazacyclododecane Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 20. Global 1,4,7,10-Tetraazacyclododecane Sales Market Share by Type (2015-2020)
Figure 21. Global 1,4,7,10-Tetraazacyclododecane Sales Market Share by Type in 2019
Figure 22. Global 1,4,7,10-Tetraazacyclododecane Revenue Market Share by Type (2015-2020)
Figure 23. Global 1,4,7,10-Tetraazacyclododecane Revenue Market Share by Type in 2019
Figure 24. Global 1,4,7,10-Tetraazacyclododecane Market Share by Price Range (2015-2020)
Figure 25. Global 1,4,7,10-Tetraazacyclododecane Sales Market Share by Application (2015-2020)
Figure 26. Global 1,4,7,10-Tetraazacyclododecane Sales Market Share by Application in 2019
Figure 27. Global 1,4,7,10-Tetraazacyclododecane Revenue Market Share by Application (2015-2020)
Figure 28. Global 1,4,7,10-Tetraazacyclododecane Revenue Market Share by Application in 2019
Figure 29. North America 1,4,7,10-Tetraazacyclododecane Sales Growth Rate 2015-2020 (K MT)
Figure 30. North America 1,4,7,10-Tetraazacyclododecane Revenue Growth Rate 2015-2020 (US$ Million)
Figure 31. North America 1,4,7,10-Tetraazacyclododecane Sales Market Share by Country in 2019
Figure 32. North America 1,4,7,10-Tetraazacyclododecane Revenue Market Share by Country in 2019
Figure 33. U.S. 1,4,7,10-Tetraazacyclododecane Sales Growth Rate (2015-2020) (K MT)
Figure 34. U.S. 1,4,7,10-Tetraazacyclododecane Revenue Growth Rate (2015-2020) (US$ Million)
Figure 35. Canada 1,4,7,10-Tetraazacyclododecane Sales Growth Rate (2015-2020) (K MT)
Figure 36. Canada 1,4,7,10-Tetraazacyclododecane Revenue Growth Rate (2015-2020) (US$ Million)
Figure 37. North America 1,4,7,10-Tetraazacyclododecane Market Share by Type in 2019
Figure 38. North America 1,4,7,10-Tetraazacyclododecane Market Share by Application in 2019
Figure 39. Europe 1,4,7,10-Tetraazacyclododecane Sales Growth Rate 2015-2020 (K MT)
Figure 40. Europe 1,4,7,10-Tetraazacyclododecane Revenue Growth Rate 2015-2020 (US$ Million)
Figure 41. Europe 1,4,7,10-Tetraazacyclododecane Sales Market Share by Country in 2019
Figure 42. Europe 1,4,7,10-Tetraazacyclododecane Revenue Market Share by Country in 2019
Figure 43. Germany 1,4,7,10-Tetraazacyclododecane Sales Growth Rate (2015-2020) (K MT)
Figure 44. Germany 1,4,7,10-Tetraazacyclododecane Revenue Growth Rate (2015-2020) (US$ Million)
Figure 45. France 1,4,7,10-Tetraazacyclododecane Sales Growth Rate (2015-2020) (K MT)
Figure 46. France 1,4,7,10-Tetraazacyclododecane Revenue Growth Rate (2015-2020) (US$ Million)
Figure 47. U.K. 1,4,7,10-Tetraazacyclododecane Sales Growth Rate (2015-2020) (K MT)
Figure 48. U.K. 1,4,7,10-Tetraazacyclododecane Revenue Growth Rate (2015-2020) (US$ Million)
Figure 49. Italy 1,4,7,10-Tetraazacyclododecane Sales Growth Rate (2015-2020) (K MT)
Figure 50. Italy 1,4,7,10-Tetraazacyclododecane Revenue Growth Rate (2015-2020) (US$ Million)
Figure 51. Russia 1,4,7,10-Tetraazacyclododecane Sales Growth Rate (2015-2020) (K MT)
Figure 52. Russia 1,4,7,10-Tetraazacyclododecane Revenue Growth Rate (2015-2020) (US$ Million)
Figure 53. Europe 1,4,7,10-Tetraazacyclododecane Market Share by Type in 2019
Figure 54. Europe 1,4,7,10-Tetraazacyclododecane Market Share by Application in 2019
Figure 55. Asia Pacific 1,4,7,10-Tetraazacyclododecane Sales Growth Rate 2015-2020 (K MT)
Figure 56. Asia Pacific 1,4,7,10-Tetraazacyclododecane Revenue Growth Rate 2015-2020 (US$ Million)
Figure 57. Asia Pacific 1,4,7,10-Tetraazacyclododecane Sales Market Share by Region in 2019
Figure 58. Asia Pacific 1,4,7,10-Tetraazacyclododecane Revenue Market Share by Region in 2019
Figure 59. China 1,4,7,10-Tetraazacyclododecane Sales Growth Rate (2015-2020) (K MT)
Figure 60. China 1,4,7,10-Tetraazacyclododecane Revenue Growth Rate (2015-2020) (US$ Million)
Figure 61. Japan 1,4,7,10-Tetraazacyclododecane Sales Growth Rate (2015-2020) (K MT)
Figure 62. Japan 1,4,7,10-Tetraazacyclododecane Revenue Growth Rate (2015-2020) (US$ Million)
Figure 63. South Korea 1,4,7,10-Tetraazacyclododecane Sales Growth Rate (2015-2020) (K MT)
Figure 64. South Korea 1,4,7,10-Tetraazacyclododecane Revenue Growth Rate (2015-2020) (US$ Million)
Figure 65. India 1,4,7,10-Tetraazacyclododecane Sales Growth Rate (2015-2020) (K MT)
Figure 66. India 1,4,7,10-Tetraazacyclododecane Revenue Growth Rate (2015-2020) (US$ Million)
Figure 67. Australia 1,4,7,10-Tetraazacyclododecane Sales Growth Rate (2015-2020) (K MT)
Figure 68. Australia 1,4,7,10-Tetraazacyclododecane Revenue Growth Rate (2015-2020) (US$ Million)
Figure 69. Taiwan 1,4,7,10-Tetraazacyclododecane Sales Growth Rate (2015-2020) (K MT)
Figure 70. Taiwan 1,4,7,10-Tetraazacyclododecane Revenue Growth Rate (2015-2020) (US$ Million)
Figure 71. Indonesia 1,4,7,10-Tetraazacyclododecane Sales Growth Rate (2015-2020) (K MT)
Figure 72. Indonesia 1,4,7,10-Tetraazacyclododecane Revenue Growth Rate (2015-2020) (US$ Million)
Figure 73. Thailand 1,4,7,10-Tetraazacyclododecane Sales Growth Rate (2015-2020) (K MT)
Figure 74. Thailand 1,4,7,10-Tetraazacyclododecane Revenue Growth Rate (2015-2020) (US$ Million)
Figure 75. Malaysia 1,4,7,10-Tetraazacyclododecane Sales Growth Rate (2015-2020) (K MT)
Figure 76. Malaysia 1,4,7,10-Tetraazacyclododecane Revenue Growth Rate (2015-2020) (US$ Million)
Figure 77. Philippines 1,4,7,10-Tetraazacyclododecane Sales Growth Rate (2015-2020) (K MT)
Figure 78. Philippines 1,4,7,10-Tetraazacyclododecane Revenue Growth Rate (2015-2020) (US$ Million)
Figure 79. Vietnam 1,4,7,10-Tetraazacyclododecane Sales Growth Rate (2015-2020) (K MT)
Figure 80. Vietnam 1,4,7,10-Tetraazacyclododecane Revenue Growth Rate (2015-2020) (US$ Million)
Figure 81. Asia Pacific 1,4,7,10-Tetraazacyclododecane Market Share by Type in 2019
Figure 82. Asia Pacific 1,4,7,10-Tetraazacyclododecane Market Share by Application in 2019
Figure 83. Latin America 1,4,7,10-Tetraazacyclododecane Sales Growth Rate 2015-2020 (K MT)
Figure 84. Latin America 1,4,7,10-Tetraazacyclododecane Revenue Growth Rate 2015-2020 (US$ Million)
Figure 85. Latin America 1,4,7,10-Tetraazacyclododecane Sales Market Share by Country in 2019
Figure 86. Latin America 1,4,7,10-Tetraazacyclododecane Revenue Market Share by Country in 2019
Figure 87. Mexico 1,4,7,10-Tetraazacyclododecane Sales Growth Rate (2015-2020) (K MT)
Figure 88. Mexico 1,4,7,10-Tetraazacyclododecane Revenue Growth Rate (2015-2020) (US$ Million)
Figure 89. Brazil 1,4,7,10-Tetraazacyclododecane Sales Growth Rate (2015-2020) (K MT)
Figure 90. Brazil 1,4,7,10-Tetraazacyclododecane Revenue Growth Rate (2015-2020) (US$ Million)
Figure 91. Argentina 1,4,7,10-Tetraazacyclododecane Sales Growth Rate (2015-2020) (K MT)
Figure 92. Argentina 1,4,7,10-Tetraazacyclododecane Revenue Growth Rate (2015-2020) (US$ Million)
Figure 93. Latin America 1,4,7,10-Tetraazacyclododecane Market Share by Type in 2019
Figure 94. Latin America 1,4,7,10-Tetraazacyclododecane Market Share by Application in 2019
Figure 95. Middle East and Africa 1,4,7,10-Tetraazacyclododecane Sales Growth Rate 2015-2020 (K MT)
Figure 96. Middle East and Africa 1,4,7,10-Tetraazacyclododecane Revenue Growth Rate 2015-2020 (US$ Million)
Figure 97. Middle East and Africa 1,4,7,10-Tetraazacyclododecane Sales Market Share by Country in 2019
Figure 98. Middle East and Africa 1,4,7,10-Tetraazacyclododecane Revenue Market Share by Country in 2019
Figure 99. Turkey 1,4,7,10-Tetraazacyclododecane Sales Growth Rate (2015-2020) (K MT)
Figure 100. Turkey 1,4,7,10-Tetraazacyclododecane Revenue Growth Rate (2015-2020) (US$ Million)
Figure 101. Saudi Arabia 1,4,7,10-Tetraazacyclododecane Sales Growth Rate (2015-2020) (K MT)
Figure 102. Saudi Arabia 1,4,7,10-Tetraazacyclododecane Revenue Growth Rate (2015-2020) (US$ Million)
Figure 103. U.A.E 1,4,7,10-Tetraazacyclododecane Sales Growth Rate (2015-2020) (K MT)
Figure 104. U.A.E 1,4,7,10-Tetraazacyclododecane Revenue Growth Rate (2015-2020) (US$ Million)
Figure 105. Middle East and Africa 1,4,7,10-Tetraazacyclododecane Market Share by Type in 2019
Figure 106. Middle East and Africa 1,4,7,10-Tetraazacyclododecane Market Share by Application in 2019
Figure 107. North America 1,4,7,10-Tetraazacyclododecane Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 108. North America 1,4,7,10-Tetraazacyclododecane Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 109. Europe 1,4,7,10-Tetraazacyclododecane Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 110. Europe 1,4,7,10-Tetraazacyclododecane Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 111. Asia Pacific 1,4,7,10-Tetraazacyclododecane Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 112. Asia Pacific 1,4,7,10-Tetraazacyclododecane Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 113. Latin America 1,4,7,10-Tetraazacyclododecane Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 114. Latin America 1,4,7,10-Tetraazacyclododecane Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 115. Middle East and Africa 1,4,7,10-Tetraazacyclododecane Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 116. Middle East and Africa 1,4,7,10-Tetraazacyclododecane Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 117. Porter's Five Forces Analysis
Figure 118. Channels of Distribution
Figure 119. Distributors Profiles
Figure 120. Bottom-up and Top-down Approaches for This Report
Figure 121. Data Triangulation
Figure 122. Key Executives Interviewed
医薬品用乳糖の世界市場（～2026年） Pharmaceutical grade lactose is produced by concentrating whey or permeate (a co-product of whey protein concentrate production) to over-saturate the lactose, then removing, refining, drying and milling the lactose crystals. Pharmaceutical grade lactose is produced to meet rigid specifications, such…- 医薬品用ゼラチンの世界市場（～2026年） Pharmaceutical grade gelatin is colorless, water soluble, translucent, and a delicate element that has a high molecular weight. It is derived from skin, white connective tissues, and bones of animals by partial hydrolysis of collagen. Gelatin is harmless and absorbable, which is why it is employed i…
- 医薬品用フルボ酸の世界市場（～2026年） Market Analysis and Insights: Global Pharmaceutical Grade Fulvic Acid Market The global Pharmaceutical Grade Fulvic Acid market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Pharmaceutical Grade Fulvic Acid Scope and Market…
- 医薬品用重炭酸ナトリウムの世界市場（～2026年） Sodium bicarbonate, commonly known as baking soda, has witnessed an increased consumption in the pharmaceutical sector. Pharma grade sodium bicarbonate is used as a pH buffering agent for electrolyte replenishing, systemic alkalizer and in topical cleansing solutions. Within the pharma grade sodium …
- 酢酸エチル用ウレタンの世界市場（～2026年） Ethyl acetate. Acts as solvent. It is low-boiling and fast-evaporating. Has excellent solvent activity, high electrical resistance, low MIR value, mild odor and low surface tension. It is non-HAP, non-SARA, readily biodegradable and REACH compliant urethane grade. Ethyl Acetate Grade Urethane is one…